Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Low-dose rate brachytherapy
• High-dose rate brachytherapy
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Genetic counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	325	482
Performance Status recorded	58%	64%
PSA completed	54%	48%
Gleason Score completed	N/A	N/A
TNM completed	13%	36%
Stage variable assigned	34%	53%

	Specialist MDT	National
No. of men with disease status determined	292	23477
Percentage of men diagnosed with metastatic disease	21%	17%
No. of men diagnosed with M1 (metastases)	60	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	46
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	12%
No. of men who received radical prostatectomy (2019)	119
Adjusted percentage of men experiencing at least one GU complication (%)	4%
No. of men who received radical radiotherapy (2019)	576
Adjusted percentage of men experiencing at least one GI complication (%)	8%